5 completed. 4 Phase 1, 1 Phase 2.
By phase and status
Follow BIIB091: new trials by email Literature Review of BIIB091 trials Research Report on BIIB091
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants
BIIB091 - Healthy Volunteer | Phase 1 | Completed | Biogen | 25 | 2024-10-16 | 2025-02-18 |
A Study to Find Out How Multiple Doses of BIIB091 Affect the Electrical Activity of the Heart in Healthy Participants
BIIB091, Moxifloxacin, BIIB091-matched Placebo - Healthy Volunteer | Phase 1 | Completed | Biogen | 69 | 2024-08-29 | 2025-03-28 |
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
BIIB091, DRF, Placebo - Relapsing Forms of Multiple Sclerosis | Phase 2 | Completed | Biogen | 127 | 2023-07-25 | 2026-02-20 |
Study of BIIB091 Formulations in Healthy Participants
BIIB091, Rabeprazole, Itraconazole - Healthy Volunteers | Phase 1 | Completed | Biogen | 59 | 2020-09-28 | 2023-04-18 |
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Healthy Adult Participants
BIIB091, Placebo - Healthy Volunteer | Phase 1 | Completed | Biogen | 64 | 2019-05-13 | 2021-03-22 |
Conditions studied
Multiple Sclerosis (1)
Sponsors
Biogen (5)
Countries
United States (4) · Bulgaria (1) · Czechia (1) · Germany (1) · Italy (1) · Poland (1) · Puerto Rico (1) · Romania (1) · Spain (1) · Switzerland (1) · United Kingdom (1)